Cargando…
T-ALL leukemia stem cell 'stemness' is epigenetically controlled by the master regulator SPI1
Leukemia stem cells (LSCs) are regarded as the origins and key therapeutic targets of leukemia, but limited knowledge is available on the key determinants of LSC ‘stemness’. Using single-cell RNA-seq analysis, we identify a master regulator, SPI1, the LSC-specific expression of which determines the...
Autores principales: | Zhu, Haichuan, Zhang, Liuzhen, Wu, Yilin, Dong, Bingjie, Guo, Weilong, Wang, Mei, Yang, Lu, Fan, Xiaoying, Tang, Yuliang, Liu, Ningshu, Lei, Xiaoguang, Wu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251627/ https://www.ncbi.nlm.nih.gov/pubmed/30412053 http://dx.doi.org/10.7554/eLife.38314 |
Ejemplares similares
-
CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells
por: Touzet, Lucas, et al.
Publicado: (2019) -
Loss of Kat2a enhances transcriptional noise and depletes acute myeloid leukemia stem-like cells
por: Domingues, Ana Filipa, et al.
Publicado: (2020) -
Global gene expression profiles of hematopoietic stem and progenitor cells from patients with chronic myeloid leukemia: the effect of in vitro culture with or without imatinib
por: Avilés‐Vázquez, Sócrates, et al.
Publicado: (2017) -
Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index
por: Bai, Kun‐Hao, et al.
Publicado: (2020) -
Crizotinib targets in glioblastoma stem cells
por: Junca, Audelaure, et al.
Publicado: (2017)